Skip to main content

Table 6 Other medications/adjuvant drugs prescribed for co-morbid disease for LN patients at the renal clinic of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia from Sep, 2016 to Oct, 2020 (n = 114)

From: Management practice and treatment outcomes of adult patients with Lupus Nephritis at the Renal Clinic of St. Paul’s Hospital Millennium Medical College, Addis Ababa, Ethiopia

Medications

Frequency (%)

Anti-malarial therapy a

98(86)

Kidney protective regimens b

100(87.7)

Antihypertensive drugs c

70(61.4)

Diuretics d

72(63.2)

Antilipemic agents e

38(33.3)

Anticoagulants f

39(34.2)

Prophylaxis for pneumocystis jiroverci pneumoniag

77(67.5)

PPIs/antacids h

66(57.9)

Antidiabetics i

10(8.8)

Antianemic agents j

22(19.3)

Dermatologic agents k

27(23.7)

Anticonvulsants/antidepressants l

3(2.6)

  1. a chloroquine
  2. b ACEIs (enalapril, lisinopril), ARBs (losartan, irbesartan)
  3. c calcium channel blockers (amilodipine, nifedipine, verapamil), beta blockers (metoprolol, carvedilol, labetalol, atenolol), hydralazine
  4. d furosemide, hydrochlorothiazide, spironolactone
  5. e atorvastatin, simvastatin
  6. f warfarin, UFH, enoxaparin, aspirin, tranexamic acid
  7. g cotrimoxazole
  8. h omeprazole, pantoprazole, esmoprazol, ranitidine
  9. i insulin, metformin
  10. j ferrous sulphate, ferrous gluconate, epoitin alpha, cyanocobalamine
  11. k fluconazole, terbinafin, miconazole, sunscreens and emollients
  12. l sertraline, phenytoin, diazepam
  13. ACEIs angiotensin converting enzyme inhibitors, ARBs angiotensin receptor blockers, UFH unfractionated heparin, PPIs proton pump inhibitors
Back to article page

BMC Nephrology

ISSN: 1471-2369

Contact us